miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop

British Journal of Cancer

Volumn 112, Issue 2, 2015, Pages 365-374

  Zhang, Y ^a   Dai, J ^a   Deng, H ^a   Wan, H ^a   Liu, M ^a   Wang, J ^b   Li, S ^b   Li, X ^a   Tang, H ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Cell cycle; Metastasis; miR 1228; p53; Proliferation

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 1228; PROTEIN P53; UNCLASSIFIED DRUG; MIRN1228 MICRORNA, HUMAN; TP53 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENETICS; CANCER GROWTH; CELL CYCLE G0 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEEDBACK SYSTEM; G1 PHASE CELL CYCLE CHECKPOINT; GENE ACTIVITY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER METABOLISM; LIVER METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; S PHASE CELL CYCLE CHECKPOINT; TUMOR INVASION; WESTERN BLOTTING; ANIMAL; BINDING SITE; CANCER TRANSPLANTATION; CELL MOTION; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SECONDARY;

ANIMALS; BASE SEQUENCE; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; FEEDBACK, PHYSIOLOGICAL; G1 PHASE CELL CYCLE CHECKPOINTS; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84922337427     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.593     Document Type: Article

References (45)

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2): 281-297.
2. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2): 215-233.
3. Basford JE, Wancata L, Hofmann SM, Silva RA, Davidson WS, Howles PN, Hui DY (2011) Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice. J Biol Chem 286(15): 13079-13087.
4. Boldrup L, Coates PJ, Wahlgren M, Laurell G, Nylander K (2012) Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins. J Carcinog 11: 18.
5. Boominathan L (2010) The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PloS One 5(5): e10615.
6. Braithwaite AW, Prives CL (2006) p53: more research and more questions. Cell Death Differ 13(6): 877-880.
7. Bueno MJ, Perez de Castro I, Malumbres M (2008) Control of cell proliferation pathways by microRNAs. Cell Cycle 7(20): 3143-3148.
8. Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J (2013) MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/beta-catenin pathway in hepatocellular carcinoma cells. Cell Signal 25(12): 2693-2701.
9. Cheung KF, Zhao J, Hao Y, Li X, Lowe AW, Cheng AS, Sung JJ, Yu J (2013) CITED2 is a novel direct effector of peroxisome proliferator-activated receptor gamma in suppressing hepatocellular carcinoma cell growth. Cancer 119(6): 1217-1226.
10. Cho WC (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42(8): 1273-1281.
11. Fares N, Peron JM (2013) [Epidemiology, natural history, and risk factors of hepatocellular carcinoma]. La Revue du Praticien 63(2): 216-217, 220-212.
12. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34(Database issue): D140-D144.
13. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (2009) CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma - A miRNA microarray analysis. Genes Chromosomes Cancer 48(7): 615-623.
14. Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24(17): 2899-2908.
15. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ (2007) A microRNA component of the p53 tumour suppressor network. Nature 447(7148): 1130-1134.
16. Hu W, Chan CS, Wu R, Zhang C, Sun Y, Song JS, Tang LH, Levine AJ, Feng Z (2010) Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 38(5): 689-699.
17. Imam JS, Buddavarapu K, Lee-Chang JS, Ganapathy S, Camosy C, Chen Y, Rao MK (2010) MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 29(35): 4971-4979.
18. Jia L, Wu J, Zhang L, Chen J, Zhong D, Xu S, Xie C, Cai J (2013) Restoration of miR-1228∗ expression suppresses epithelial-mesenchymal transition in gastric cancer. PloS One 8(3): e58637.
19. Jing Z, Nan KJ, Hu ML (2005) Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. World J Gastroenterol 11(13): 1910-1916.
20. Kong X, Peng B, Yang Y, Zhang P, Qin B, Han D, Wang C, Dang Y, Liu JO, Yu L (2013) p53 Represses transcription of RING finger LIM domain-binding protein RLIM through Sp1. PLoS One 8(5): e62832.
21. Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V, Lodish HF, Lim B (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev 23(7): 862-876.
22. Lee SY, Lee GR, Woo DH, Park NH, Cha HJ, Moon YH, Han IS (2013) Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells. Cell Cycle 12(1): 67-75.
23. Levine AJ, Hu W, Feng Z (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ 13(6): 1027-1036.
24. Lim SO, Kim H, Jung G (2010) p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma. FEBS Lett 584(11): 2231-2236.
25. Lynam-Lennon N, Maher SG, Reynolds JV (2009) The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 84(1): 55-71.
26. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA: a cancer journal for clinicians 55(2): 74-108.
27. Schickel R, Boyerinas B, Park SM, Peter ME (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27(45): 5959-5974.
28. Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, Schirmacher P, Breuhahn K (2007) Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 46(3): 759-768.
29. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K (2009) Modulation of microRNA processing by p53. Nature 460(7254): 529-533.
30. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6(13): 1586-1593.
31. Urbich C, Kuehbacher A, Dimmeler S (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79(4): 581-588.
32. Vayssade M, Haddada H, Faridoni-Laurens L, Tourpin S, Valent A, Benard J, Ahomadegbe JC (2005) P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int J Cancer 116(6): 860-869.
33. Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137(3): 413-431.
34. Wang B, Feng P, Xiao Z, Ren EC (2009) LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma. J Hepatol 50(3): 528-537.
35. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K (2010) TGF beta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29(12): 1787-1797.
36. Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X (2011) miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179(5): 2580-2588.
37. Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L (2013) miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer 49(18): 3924-3935.
38. Wu TT, Hsieh YH, Hsieh YS, Liu JY (2008) Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J Cell Biochem 103(1): 9-20.
39. Xie Q, Chen XM, Lu FM, Zhang T, Hao ML, Wang YF, Zhao J, McCrae MA, Zhuang H (2012) Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Cancer 118(9): 2431-2442.
40. Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F, Xie X, Zhou C, Lu W (2013) Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 32(8): 976-987.
41. Yan B, Zhao JL (2012) miR-1228 prevents cellular apoptosis through targeting of MOAP1 protein. Apoptosis 17(7): 717-724.
42. Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, Liu MF, Lu MH, Tang Y, Yu HY, Sun SH (2009) Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J 28(18): 2719-2732.
43. Yan Y, Luo YC, Wan HY, Wang J, Zhang PP, Liu M, Li X, Li S, Tang H (2013) MicroRNA-10a Is Involved in the Metastatic Process by Regulating Eph Tyrosine Kinase Receptor A4-Mediated Epithelial-Mesenchymal Transition and Adhesion in Hepatoma Cells. Hepatology 57(2): 667-677.
44. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S, Deng Y, Zhao J, Jiang S, Yuan Y, Wang HY, Cheng SQ, Xie D, Wang XF (2012) TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22(3): 291-303.
45. Zhang L, Wang JN, Tang JM, Kong X, Yang JY, Zheng F, Guo LY, Huang YZ, Zhang L, Tian L, Cao SF, Tuo CH, Guo HL, Chen SY (2012) VEGF is essential for the growth and migration of human hepatocellular carcinoma cells. Mol Biol Rep 39(5): 5085-5093.